학술논문

Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Document Type
Article
Source
In The Lancet Rheumatology April 2024 6(4):e226-e236
Subject
Primary Research
Articles
Language
ISSN
2665-9913